Designer circuit controlling diet-induced obesity
US-2015368666-A1 · Dec 24, 2015 · US
US2017333360A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017333360-A1 |
| Application number | US-201715615520-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 6, 2017 |
| Priority date | Dec 23, 2011 |
| Publication date | Nov 23, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Microencapsulation of bioactive and chemical cargo in a stable, cross-linked polymer matrix is presented that results in small particle sizes and is easily scaled-up for industrial applications. A formulation of a salt of an acid soluble multivalent ion, an acid neutralized with a volatile base and one or more monomers that cross-link in the presence of multivalent ions is atomized into droplets. Cross-linking is achieved upon atomization where the volatile base is vaporized resulting in a reduction of the pH of the formulation and the temporal release of multivalent ions from the salt that cross-link the monomers forming a capsule. The incorporation of additional polymers or hydrophobic compounds in the formulation allows control of hydration properties of the particles to control the release of the encapsulated compounds. The operational parameters can also be controlled to affect capsule properties such as particle-size and particle-size distribution.
Opening claim text (preview).
We claim: 1 . A method of cross-linking polymer molecules, comprising: (a) mixing monomer molecules, at least one salt of an acid soluble multivalent ion and an acid neutralized with a volatile base; and (b) volatilizing said volatile base, thereby liberating said multivalent ions and initiating cross-linking of the monomer molecules. 2 . A method as recited in claim 1 , wherein said monomer is selected from the group of monomers consisting of alginates, polygalacturonates, chitosan, collagen, latex, soy proteins and whey proteins. 3 . A method as recited in claim 1 , wherein said multivalent ion is a divalent cation. 4 . A method as recited in claim 3 , wherein said divalent cation is selected from the group of cations consisting of barium (Ba 2+ ), calcium (Ca 2+ ), chromium (Cr 2+ ), copper (Cu 2+ ), iron (Fe 2+ ), magnesium (Mg 2+ ) and zinc (Zn 2+ ). 5 . A method as recited in claim 1 , wherein said acid is an organic acid selected from the group of acids consisting of adipic acid, acrylic acid, glutaric acid, succinic acid, ascorbic acid, gallic acid and caffeic acid. 6 . A method as recited in claim 1 , wherein said volatile base is selected from the group of volatile bases consisting of ammonia, methylamine, trimethylamine, ethylamine, diethylamine and triethylamine.
combined with gelification or coagulation · CPC title
Pectin; Derivatives thereof · CPC title
Pulverisation by spraying · CPC title
Serum albumin · CPC title
resulting in granules or microspheres of the matrix type containing more than 5% of excipient · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.